Management

An industry executive over 24 years of strategic global operational experience in large healthcare focused multinational public and private corporations. Since 2016, Dr. Bürgi-Krishnamurthy is the Managing Director of Health Bytes, LLC a Switzerland-based financial and management consultancy firm focused on pharmaceutical, biotechnology, medical technology, digital health, and life sciences sectors. Since 2018, he is also a senior consultant to Celtic Asset and Equity Partners in Dublin, a boutique consultancy specialized in SPACs. Since 2022, he is also the Chief Financial Officer of AXIOS Sustainable Growth Acquisition Corporation (NYSE: AXAC) looking to acquire Agtech and plant-based protein technology companies. Furthermore, between 2019 and 2022, he was also a member of Board of Directors of Thermal Medical Switzerland Ltd., a Swiss domiciled limited company specialized in development and global marketing of medical devices. Prior to his current engagements, Dr. Bürgi-Krishnamurthy held senior global sales and marketing positions at Radiometer Medical ApS, a group company of Danaher Corporation (NYSE: DHR). Earlier in his career, Dr. Bürgi-Krishnamurthy held senior positions in healthcare business management for Catalent, Inc. (NYSE: CTLT), Octapharma AG (“Octapharma”), Thermo Fisher Scientific, Inc. (NYSE: TMO), Straumann Holding AG (XSWX: STMN) and Deloitte Consulting AG.

Dr. Bürgi-Krishnamurthy has a PhD from University of Zurich, Switzerland and an MBA from Strathclyde Business School, UK.